Piper Sandler Maintains Overweight on Colgate-Palmolive, Raises Price Target to $96

Benzinga Newsdesk www.benzinga.com Positive 82.1%

Neg 0% Neu 0% Pos 82.1%

Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target from $92 to $96.